Cohort 1: Days 1-7 Bemnifosbuvir (BEM)/Ruzasvir (RZR) co-administered. Days 8-17 Bemnifosbuvir (BEM)/Ruzasvir (RZR) co-administered + Biktarvy (BIK). Days 18-24 BIK
AT-01B-006
Phase 1 small_molecule completed
Quick answer
Cohort 1: Days 1-7 Bemnifosbuvir (BEM)/Ruzasvir (RZR) co-administered. Days 8-17 Bemnifosbuvir (BEM)/Ruzasvir (RZR) co-administered + Biktarvy (BIK). Days 18-24 BIK for Healthy Volunteer Study is a Phase 1 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- Healthy Volunteer Study
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed